Imatinib and fatigue Patient Reports February 11, 2012

Imatinib Side Effects Report #6046566-X
Imatinib side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2009. Male patient, 42 years of age, was diagnosed with neoplasm malignant and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anhedonia, apathy, depressed mood, fatigue, insomnia, irritability, major depression, memory impairment. Imatinib dosage: 400 MG DAILY. During the same period patient was treated with VENLAFAXINE, METHYLPHENIDATE, TRAZODONE. Patient recovered.

Imatinib Side Effects Report #5096852-5
Imatinib side effect was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Female patient, 70 years of age, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: confusional state, disease progression, fatigue, hemiparesis, neurological symptom, petit mal epilepsy, somnolence, tooth extraction. Imatinib dosage: 400 MG QD. During the same period patient was treated with HYDROXYUREA, PRILOSEC, POTASSIUM CHLORIDE, LASIX. Patient died on 08/27/2006.

Imatinib Side Effects Report #5212029-4
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Female patient, 61 years of age, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: confusional state, fatigue, hallucination, hypoaesthesia, mental status changes, visual disturbance. Imatinib dosage: 500 MG BID. During the same period patient was treated with HYDROXYUREA, NORVASC, DECADRON, DILANTIN, LIPITOR. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5126072-7
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: brain oedema, brain scan abnormal, confusional state, fatigue, headache , hemiparesis, malignant neoplasm progression, vision blurred. Imatinib dosage: 400 MG QD. During the same period patient was treated with HYDROXYUREA, KEPPRA, LIPITOR, METAMUCIL, ZOFRAN. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5002201-0
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Female patient, weighting 132.9 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, cough, disease progression, dyspnoea, fatigue, lung infiltration, pneumocystis jiroveci pneumonia, pyrexia. Imatinib dosage: 400 MG DAILY PO. During the same period patient was treated with HYDREA, DEXAMETHASONE, PREVACID, AMBIEN, ALLEGRA, TOPROL. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5442574-8
Imatinib side effect was reported by a Health Professional from GREECE on Aug 15, 2007. Male patient, 74 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: asthenia, bence jones proteinuria, blood calcium increased, bone pain, fatigue, multiple myeloma , normochromic normocytic anaemia, red blood cell sedimentation rate abnormal, x-ray abnormal. Imatinib dosage: 400 MG, QD. Patient died.

Imatinib Side Effects Report #5370598-8
Imatinib side effect was reported by a Physician from CANADA on June 18, 2007. Male patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , disease progression, fatigue, hepatic embolisation, leukopenia, liver disorder, metastases to liver. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5375834-X
Imatinib side effect was reported by a Physician from CANADA on June 26, 2007. Male patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , disease progression, fatigue, haematocrit decreased, haemoglobin decreased, hepatic embolisation, leukopenia. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5385019-9
Imatinib side effect was reported by a Physician from CANADA on July 03, 2007. Male patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , fatigue, haematocrit decreased, haemoglobin decreased, hepatic embolisation, leukopenia, liver disorder. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE. Patient recovered.


Imatinib Side Effects Report #4640430-6
Imatinib side effect was reported by a Consumer or non-health professional from on Apr 15, 2005. Male patient, 58 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, fatigue, leukopenia, neutropenia, night sweats. Imatinib dosage: 600 MG/D. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #6124711-5
Imatinib side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2009. Female patient was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: fatigue, gastrectomy, malignant neoplasm progression. Imatinib dosage: 300 MG DAILY. During the same period patient was treated with SUNITINIB MALATE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5119770-2
Imatinib side effect was reported by a Health Professional from CANADA on Sept 21, 2006. Male patient, 61 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow failure, chromosome abnormality, chronic myeloid leukaemia, fatigue, haemoglobin decreased, marrow hyperplasia, neutropenia, pancytopenia. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #4544795-5
Imatinib side effect was reported by a Physician from on Oct 07, 2004. Female patient, 57 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, fatigue, hepatitis , international normalised ratio increased, jaundice . Imatinib dosage: 400 MG/DAY. During the same period patient was treated with SIMVASTATIN. Patient recovered.

Imatinib Side Effects Report #5480109-4
Imatinib side effect was reported by a Health Professional from UNITED KINGDOM on Oct 02, 2007. Female patient, 54 years of age, was diagnosed with chronic myeloid leukaemia, hypothyroidism and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anti-thyroid antibody positive, blood thyroid stimulating hormone increased, fatigue, hypothyroidism, weight increased. Imatinib dosage: 800 MG/D. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.


Imatinib Side Effects Report #5100039-7
Imatinib side effect was reported by a Physician from IRELAND on Aug 28, 2006. Male patient, 37 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone pain, fatigue, periorbital oedema, scrotal mass, testis cancer. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #5153960-8
Imatinib side effect was reported by a Physician from IRELAND on Aug 28, 2006. Male patient, 37 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone pain, fatigue, periorbital oedema, scrotal mass, testicular neoplasm. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #5669602-9
Imatinib side effect was reported by a Health Professional from TURKEY on Mar 07, 2008. Male patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: asthenia, chloroma, cytogenetic analysis abnormal, fatigue, haemoglobin decreased, hepatosplenomegaly, malignant neoplasm progression, mass, oedema. Imatinib dosage: 400 MG/D. Patient died.

Imatinib Side Effects Report #4865944-5
Imatinib side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2005. Female patient, 72 years of age, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blood calcium increased, blood lactate dehydrogenase increased, bone pain, chromosome analysis abnormal, fatigue, malignant neoplasm progression, pancytopenia, parathyroid hormone-related protein increased, platelet count decreased. Imatinib dosage: 400 MG/D. Patient died on 05/31/2002.

Imatinib Side Effects Report #5064512-2
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 18, 2006. Female patient, 57 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chills, fatigue, hepatic function abnormal, lung consolidation, lung neoplasm, neutropenia, pleurectomy, pulmonary mass, pulmonary necrosis. Imatinib dosage: unknown. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5258416-X
Imatinib side effect was reported by a Pharmacist from UNITED STATES on Mar 06, 2007. Female patient, child 10 years of age, weighting 109.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: fatigue, hypotension, oedema peripheral, somnolence. Imatinib dosage: 300 MG PO DAILY. During the same period patient was treated with STRATTERA, CLONIDINE, PROTONIX, ZOFRAN, SEPTRA. Patient was hospitalized. Patient recovered.